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Thus, in growing cells in which TOR is active, IFH1 bindsRibosome Biogenesis:
to FHL1 at RP gene promoters to activate gene expres-Giant Steps for a Giant Problem sion (see Figure 1). By contrast, following inactivation
of TOR by rapamycin, CRF1 displaces IFH1 and binds
instead to FHL1, forming a CRF1-FHL1 complex that is
unable to support transcription. The physical basis for
mutually exclusive binding of FHL1 to either IFH1 or
CRF1 is due to the presence of a common binding do-In this issue of Cell, the Hall group describes how the
main within the latter two proteins, termed a Forkheadrapamycin-sensitive TOR signaling network controls
binding domain (FHB), which compete for binding to aribosomal protein (RP) gene expression via the Fork-
specific region of FHL1. In summary, FHL1 is proposedhead-like transcription factor FHL1 in budding yeast
to bind constitutively to RP gene promoters and act as(Martin et al., 2004). These findings represent a crucial
either an activator or repressor of transcription, de-advance in our understanding of the mechanism by
pending on whether it is associated with IFH1 or CRF1.which TOR regulates ribosomebiogenesis in response
Implicit in the above scheme is the feature that CRF1to environmental cues.
represents the crucial point of regulation in this system.
How is this accomplished? In what appears to be an
increasingly familiar regulatory mechanism for tran-A hallmark of cell growth regulation in both prokaryotic
scription factors whose activities are controlled by TOR,and eukaryotic organisms is a tight coupling between
the answer lies in the finding that the nucleocytoplasmicextracellular conditions and the synthesis of macromol-
localization of CRF1 is controlled by reversible phos-ecules, in particular that of ribosomes. In microorgan-
phorylation and is susceptible to rapamycin. Thus, inisms, synthesis of ribosomes and other components of
growing cells in which TOR is active, CRF1 is dephos-the protein biosynthetic machinery are linked to nutrient
phorylated and sequestered in the cytoplasm where itavailability and stress-related signals, whereas, in multi-
is unable to interact with FHL1; following rapamycincellular eukaryotes, additional hormonal andgrowth fac-
treatment, however, CRF1 becomes phosphorylatedtor-derived cues also play important roles (Warner et
and enters the nucleus to displace IFH1 fromFHL1 (Mar-al., 2001). This is in part because the construction of
tin et al., 2004). The Hall group has even identified YAK1new ribosomes is an extremely costly undertaking for
as the kinase that phosphorylates CRF1 in responsea cell, in terms of both energy resources and required
to rapamycin treatment (Martin et al., 2004). Previousbuilding materials. In S. cerevisiae, the decision to com-
studies by this group have linked YAK1 to both TORmit to new ribosome synthesis is controlled primarily at
and ras-cAMP-PKA signaling (Schmelzle et al., 2004).the transcriptional level, where environmental signals
Thus, in total, an entire pathway has been outlined that
are coupled to RP gene and ribosomal RNA (rRNA) ex-
links nutrients to CRF1 regulation via a TOR/PKA/YAK1
pression (Warner et al., 2001). It has become clear in
cascade (Martin et al., 2004). TOR aficionados are likely
recent years that the conserved TOR kinases (TOR1 and to appreciate this model both for its simplicity and as
TOR2) play an important positive role in the expression a basis for further experimentation. However, this model
of these genes (Jacinto and Hall, 2003; Warner et al., is unlikely to represent the end of the story.
2001). The TOR kinases are targets of the clinically im- For example, in cells lacking CRF1 activity, RP gene
portant antibiotic rapamycin and are components of an expression remains considerably sensitive to inhibition
essential signaling network (referred to simply as “TOR”) by rapamycin, implying that additional regulatory con-
that couples nutrient-derived signals to a plethora of nectionsmust exist between these genes andTOR (Mar-
growth-related cellular processes (Jacinto and Hall, tin et al., 2004). One likely connection is SFP1, a zinc
2003). What has remained elusive is the identity of the finger transcription factor identified independently by
transcription factors that specifically link TOR to RP both the Tyers and O’Shea groups as a rapamycin-sen-
gene and rRNA gene activity. This situation has now sitive protein required for optimal RP gene expression
changed dramatically, due to the present work from the (Jorgensen et al., 2004;Marion et al., 2004). Interestingly,
Hall group (Martin et al., 2004), as well as other recent the O’Shea group observed that this protein is normally
reports (Jorgensen et al., 2004; Marion et al., 2004). present at RP gene promoters in growing cells but then
The Hall group (Martin et al., 2004) has identified the exits the nucleus following rapamycin treatment or upon
Forkhead-like transcription factor FHL1 as a critical reg- nutrient starvation (Marion et al., 2004), quite the oppo-
ulator of RP gene expression that responds specifically site of what is observed for CRF1 (see Figure 1). One
to TOR. The immediate impetus for their study was the issue to be resolved iswhether SFP1 is dedicated strictly
finding from recent genome-wide transcription factor to RP gene expression or rather plays a more general
binding analyses that FHL1 is enriched at RP gene pro- role in ribosome biogenesis. In this regard, SFP1 was
moters (Bar-Joseph et al., 2003). The Hall group has identified originally as an important factor controlling
built upon these initial results to unveil a remarkable the expression of a large family of genes required for
regulatory system that, in addition to FHL1, involves two ribosomebiogenesis (the so-called ribi regulon) (Jorgen-
other proteins, IFH1 and CRF1, which turn out to act as sen et al., 2002). Also of importance is the fact that the
O’Shea group has observed that SFP1 remains sensitivea coactivator and a corepressor of FHL1, respectively.
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Figure 1. TOR Controls Novel Components
Involved in RP Gene Expression during Ribo-
somal Biogenesis
(A) When TOR is active (rich nutrient condi-
tions), the Forkhead-like transcription factor
FHL1, in associationwith its coactivator IFH1,
and the transcription factor SFP1 interact
with RP gene promoters to stimulate expres-
sion. TOR acts to prevent escape of SFP1
from the nucleus and keep CRF1, a corepres-
sor for FHL1, within the cytoplasm.
(B)When TOR is inactive (poor nutrient condi-
tions or upon rapamycin treatment) SFP1
leaves and CFR1 enters the nucleus, where
the latter displaces IFH1 from FHL1. The net
result of these events is abolished RP gene
expression.
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Mol. Cell. Biol. 18, 4463–4470.tion. Previous studies have also shown that TOR con-
trols 35S and 5S rRNA synthesis via RNA Pol I and Pol
III, respectively (Powers and Walter, 1999; Zaragoza et
al., 1998). How are the activities of each of the three
major cellular RNA polymerases coordinated for the bal-
anced production of new ribosomal components? Part
of the answer may lie in the fact that FHL1 is also likely
to be involved in regulation of RNA Pol I and III (dis-
cussed in Martin et al. [2004]). However, it is clear that
many other factors are involved and that their relation-
ship to TOR remains to be clarified (Warner et al., 2001).
In other words, for this field, several more giant steps
await.
